 Michael Cripps
Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 7 | 2023 | 46 | 3.490 |
Why?
| | Wounds and Injuries | 14 | 2023 | 749 | 2.210 |
Why?
| | Cholecystitis, Acute | 5 | 2023 | 16 | 1.940 |
Why?
| | Venous Thromboembolism | 5 | 2023 | 231 | 1.800 |
Why?
| | Cholecystitis | 3 | 2023 | 17 | 1.470 |
Why?
| | Appendicitis | 4 | 2020 | 114 | 1.360 |
Why?
| | Anticoagulants | 5 | 2023 | 550 | 1.270 |
Why?
| | Emergency Treatment | 2 | 2020 | 113 | 1.210 |
Why?
| | Postoperative Complications | 6 | 2021 | 2128 | 1.150 |
Why?
| | Trauma Centers | 10 | 2023 | 362 | 0.970 |
Why?
| | Retrospective Studies | 31 | 2023 | 12551 | 0.930 |
Why?
| | Hemorrhage | 5 | 2021 | 620 | 0.900 |
Why?
| | Appendectomy | 3 | 2020 | 67 | 0.900 |
Why?
| | Burns | 4 | 2023 | 237 | 0.840 |
Why?
| | Simulation Training | 2 | 2022 | 61 | 0.810 |
Why?
| | Machine Learning | 2 | 2023 | 316 | 0.800 |
Why?
| | Artificial Intelligence | 1 | 2023 | 144 | 0.790 |
Why?
| | Time-to-Treatment | 2 | 2020 | 147 | 0.770 |
Why?
| | Abdomen | 2 | 2018 | 99 | 0.750 |
Why?
| | Rib Fractures | 1 | 2021 | 25 | 0.730 |
Why?
| | Length of Stay | 7 | 2021 | 962 | 0.720 |
Why?
| | Pain Management | 2 | 2021 | 288 | 0.710 |
Why?
| | Nerve Block | 1 | 2021 | 60 | 0.700 |
Why?
| | Critical Pathways | 1 | 2021 | 75 | 0.690 |
Why?
| | Enoxaparin | 3 | 2023 | 52 | 0.680 |
Why?
| | Blood Coagulation | 2 | 2018 | 218 | 0.670 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 321 | 0.670 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 151 | 0.640 |
Why?
| | Emergency Medical Services | 2 | 2023 | 590 | 0.640 |
Why?
| | Specialties, Surgical | 1 | 2020 | 70 | 0.640 |
Why?
| | Kaolin | 1 | 2018 | 5 | 0.630 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2019 | 36 | 0.630 |
Why?
| | Factor Xa | 1 | 2018 | 32 | 0.630 |
Why?
| | Vitamin K | 1 | 2018 | 42 | 0.610 |
Why?
| | Adult | 32 | 2023 | 30550 | 0.610 |
Why?
| | Thrombelastography | 2 | 2019 | 180 | 0.610 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2540 | 0.600 |
Why?
| | Airway Extubation | 1 | 2018 | 43 | 0.600 |
Why?
| | Laparoscopy | 2 | 2022 | 398 | 0.600 |
Why?
| | End Stage Liver Disease | 1 | 2019 | 63 | 0.600 |
Why?
| | Hemostatics | 1 | 2018 | 47 | 0.600 |
Why?
| | Prospective Studies | 14 | 2023 | 6220 | 0.580 |
Why?
| | Operative Time | 5 | 2023 | 106 | 0.570 |
Why?
| | Humans | 62 | 2023 | 114689 | 0.570 |
Why?
| | Atrial Flutter | 1 | 2017 | 25 | 0.570 |
Why?
| | Middle Aged | 28 | 2023 | 26737 | 0.560 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 42 | 0.560 |
Why?
| | Appendix | 1 | 2017 | 27 | 0.550 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 932 | 0.550 |
Why?
| | Internship and Residency | 3 | 2022 | 926 | 0.540 |
Why?
| | Algorithms | 1 | 2023 | 1469 | 0.540 |
Why?
| | Injury Severity Score | 7 | 2020 | 499 | 0.520 |
Why?
| | Critical Illness | 2 | 2019 | 646 | 0.520 |
Why?
| | Biomedical Research | 1 | 2021 | 585 | 0.500 |
Why?
| | Patient Safety | 1 | 2018 | 277 | 0.500 |
Why?
| | Treatment Outcome | 16 | 2023 | 9088 | 0.500 |
Why?
| | Shock, Hemorrhagic | 4 | 2021 | 199 | 0.490 |
Why?
| | Male | 36 | 2023 | 55599 | 0.490 |
Why?
| | Blood Transfusion | 2 | 2018 | 293 | 0.480 |
Why?
| | Female | 38 | 2023 | 59511 | 0.480 |
Why?
| | Hospitalization | 3 | 2022 | 1752 | 0.470 |
Why?
| | Resuscitation | 6 | 2022 | 252 | 0.440 |
Why?
| | Mass Screening | 4 | 2023 | 1004 | 0.440 |
Why?
| | Atrial Fibrillation | 1 | 2017 | 322 | 0.440 |
Why?
| | Clinical Competence | 2 | 2022 | 893 | 0.420 |
Why?
| | Texas | 4 | 2019 | 188 | 0.380 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2010 | 2 | 0.360 |
Why?
| | Wandering Spleen | 1 | 2010 | 2 | 0.350 |
Why?
| | Operating Rooms | 3 | 2022 | 86 | 0.350 |
Why?
| | Risk Assessment | 10 | 2021 | 2968 | 0.330 |
Why?
| | Head Injuries, Penetrating | 1 | 2009 | 7 | 0.320 |
Why?
| | Safety-net Providers | 3 | 2019 | 95 | 0.320 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2020 | 79 | 0.320 |
Why?
| | Aged | 14 | 2021 | 19074 | 0.310 |
Why?
| | Time Factors | 9 | 2020 | 6116 | 0.310 |
Why?
| | Geriatric Assessment | 2 | 2020 | 176 | 0.310 |
Why?
| | Abdominal Abscess | 2 | 2020 | 25 | 0.310 |
Why?
| | Multiple Trauma | 1 | 2009 | 96 | 0.300 |
Why?
| | Hospitals | 2 | 2022 | 581 | 0.290 |
Why?
| | Blood Coagulation Tests | 2 | 2018 | 57 | 0.290 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2018 | 40 | 0.290 |
Why?
| | Wounds, Gunshot | 2 | 2017 | 190 | 0.280 |
Why?
| | Triage | 1 | 2009 | 199 | 0.270 |
Why?
| | Young Adult | 9 | 2023 | 10470 | 0.260 |
Why?
| | Reproducibility of Results | 5 | 2021 | 2765 | 0.260 |
Why?
| | Choledocholithiasis | 2 | 2015 | 14 | 0.250 |
Why?
| | Predictive Value of Tests | 4 | 2022 | 1796 | 0.250 |
Why?
| | Cause of Death | 3 | 2017 | 361 | 0.250 |
Why?
| | Adolescent | 6 | 2023 | 17848 | 0.220 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 4623 | 0.210 |
Why?
| | Emergency Service, Hospital | 4 | 2023 | 1815 | 0.210 |
Why?
| | ROC Curve | 2 | 2022 | 442 | 0.200 |
Why?
| | Aged, 80 and over | 5 | 2020 | 6347 | 0.200 |
Why?
| | Time Perception | 1 | 2022 | 24 | 0.200 |
Why?
| | Health Plan Implementation | 2 | 2020 | 132 | 0.200 |
Why?
| | General Surgery | 2 | 2020 | 127 | 0.190 |
Why?
| | Patient Handoff | 1 | 2021 | 26 | 0.190 |
Why?
| | Balloon Occlusion | 1 | 2021 | 26 | 0.190 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1214 | 0.190 |
Why?
| | Intubation, Intratracheal | 1 | 2023 | 216 | 0.190 |
Why?
| | Paraspinal Muscles | 1 | 2021 | 11 | 0.190 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 90 | 0.180 |
Why?
| | Trauma Severity Indices | 1 | 2021 | 114 | 0.180 |
Why?
| | Bias | 1 | 2021 | 179 | 0.180 |
Why?
| | Anesthetics, Local | 1 | 2021 | 81 | 0.170 |
Why?
| | Soft Tissue Infections | 1 | 2020 | 30 | 0.170 |
Why?
| | Laparotomy | 1 | 2020 | 103 | 0.170 |
Why?
| | United States Social Security Administration | 1 | 2019 | 2 | 0.170 |
Why?
| | Diphenoxylate | 1 | 2019 | 5 | 0.170 |
Why?
| | Mycoses | 1 | 2020 | 67 | 0.170 |
Why?
| | Ileus | 1 | 2019 | 10 | 0.170 |
Why?
| | Loperamide | 1 | 2019 | 10 | 0.170 |
Why?
| | Violence | 2 | 2023 | 202 | 0.170 |
Why?
| | Metoclopramide | 1 | 2019 | 16 | 0.170 |
Why?
| | Erythromycin | 1 | 2019 | 24 | 0.170 |
Why?
| | Fasciitis, Necrotizing | 1 | 2019 | 9 | 0.170 |
Why?
| | Antifungal Agents | 1 | 2020 | 128 | 0.170 |
Why?
| | Diet Therapy | 1 | 2019 | 36 | 0.170 |
Why?
| | Surgicenters | 1 | 2019 | 6 | 0.160 |
Why?
| | Risk Factors | 6 | 2023 | 8632 | 0.160 |
Why?
| | Abdominal Injuries | 1 | 2020 | 108 | 0.160 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2018 | 8 | 0.160 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 48 | 0.160 |
Why?
| | Publishing | 1 | 2020 | 124 | 0.160 |
Why?
| | Program Evaluation | 2 | 2020 | 822 | 0.160 |
Why?
| | Viscoelastic Substances | 1 | 2018 | 9 | 0.160 |
Why?
| | Surgical Wound Infection | 1 | 2021 | 248 | 0.160 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 126 | 0.160 |
Why?
| | Dabigatran | 1 | 2018 | 22 | 0.160 |
Why?
| | Hospitals, University | 1 | 2019 | 172 | 0.160 |
Why?
| | Conversion to Open Surgery | 1 | 2018 | 14 | 0.160 |
Why?
| | Pipecolic Acids | 1 | 2018 | 23 | 0.150 |
Why?
| | Diarrhea | 1 | 2019 | 171 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 303 | 0.150 |
Why?
| | Photoperiod | 1 | 2018 | 48 | 0.150 |
Why?
| | Bandages | 1 | 2018 | 31 | 0.150 |
Why?
| | Antithrombins | 1 | 2018 | 49 | 0.150 |
Why?
| | Hospital Mortality | 5 | 2020 | 776 | 0.150 |
Why?
| | Logistic Models | 3 | 2019 | 1841 | 0.150 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 125 | 0.150 |
Why?
| | Enteral Nutrition | 1 | 2019 | 160 | 0.150 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 207 | 0.150 |
Why?
| | Information Storage and Retrieval | 1 | 2018 | 106 | 0.150 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 26 | 0.150 |
Why?
| | Emergencies | 1 | 2018 | 146 | 0.150 |
Why?
| | Myocardial Contusions | 1 | 2017 | 1 | 0.150 |
Why?
| | Endovascular Procedures | 1 | 2021 | 269 | 0.150 |
Why?
| | Thorax | 1 | 2017 | 40 | 0.150 |
Why?
| | Cohort Studies | 3 | 2020 | 4895 | 0.150 |
Why?
| | Quality Improvement | 3 | 2020 | 950 | 0.150 |
Why?
| | Accidental Falls | 1 | 2020 | 151 | 0.140 |
Why?
| | Thoracic Vertebrae | 1 | 2017 | 68 | 0.140 |
Why?
| | Factor Xa Inhibitors | 1 | 2018 | 138 | 0.140 |
Why?
| | Patient Transfer | 1 | 2019 | 143 | 0.140 |
Why?
| | Tachycardia | 1 | 2017 | 50 | 0.140 |
Why?
| | Police | 1 | 2017 | 30 | 0.140 |
Why?
| | Smartphone | 1 | 2018 | 73 | 0.140 |
Why?
| | Arginine | 1 | 2018 | 238 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2017 | 47 | 0.140 |
Why?
| | Heparin | 1 | 2018 | 224 | 0.140 |
Why?
| | Research Design | 1 | 2023 | 928 | 0.140 |
Why?
| | Blood Viscosity | 1 | 2016 | 16 | 0.140 |
Why?
| | Pelvis | 1 | 2017 | 90 | 0.140 |
Why?
| | Critical Care | 1 | 2021 | 476 | 0.140 |
Why?
| | Physical Therapy Modalities | 1 | 2020 | 265 | 0.140 |
Why?
| | Rivaroxaban | 1 | 2018 | 211 | 0.140 |
Why?
| | Occupational Injuries | 1 | 2017 | 46 | 0.140 |
Why?
| | Substance Abuse Detection | 1 | 2017 | 62 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 544 | 0.130 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 84 | 0.130 |
Why?
| | Radiography, Interventional | 1 | 2016 | 104 | 0.130 |
Why?
| | Cholecystectomy | 3 | 2023 | 45 | 0.130 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 210 | 0.130 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 176 | 0.130 |
Why?
| | Blood Safety | 1 | 2015 | 10 | 0.130 |
Why?
| | Platelet Transfusion | 1 | 2016 | 64 | 0.120 |
Why?
| | Medical Marijuana | 1 | 2017 | 97 | 0.120 |
Why?
| | Sulfonamides | 1 | 2018 | 445 | 0.120 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2018 | 401 | 0.120 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 368 | 0.120 |
Why?
| | Cryopreservation | 1 | 2015 | 92 | 0.120 |
Why?
| | Benchmarking | 1 | 2015 | 161 | 0.110 |
Why?
| | Blood Coagulation Disorders | 1 | 2016 | 197 | 0.110 |
Why?
| | Exsanguination | 1 | 2013 | 16 | 0.110 |
Why?
| | Erythrocyte Transfusion | 1 | 2015 | 189 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1395 | 0.110 |
Why?
| | Burn Units | 3 | 2019 | 26 | 0.110 |
Why?
| | Chronic Pain | 1 | 2017 | 210 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1430 | 0.110 |
Why?
| | Patient Discharge | 1 | 2019 | 772 | 0.110 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 275 | 0.110 |
Why?
| | United States | 8 | 2022 | 12183 | 0.100 |
Why?
| | Glasgow Coma Scale | 1 | 2013 | 153 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2016 | 355 | 0.100 |
Why?
| | Suicide | 1 | 2018 | 506 | 0.100 |
Why?
| | Blood Preservation | 1 | 2015 | 263 | 0.100 |
Why?
| | Antifibrinolytic Agents | 1 | 2012 | 50 | 0.100 |
Why?
| | Child Abuse | 1 | 2016 | 456 | 0.090 |
Why?
| | Age Factors | 4 | 2020 | 2894 | 0.090 |
Why?
| | Surgical Mesh | 1 | 2010 | 40 | 0.090 |
Why?
| | Malaria | 1 | 2010 | 48 | 0.080 |
Why?
| | Gastrointestinal Motility | 2 | 2019 | 25 | 0.080 |
Why?
| | Brain Injuries | 1 | 2014 | 461 | 0.080 |
Why?
| | Splanchnic Circulation | 1 | 2009 | 12 | 0.080 |
Why?
| | Survival Rate | 3 | 2020 | 1644 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2020 | 4411 | 0.080 |
Why?
| | Tungsten | 1 | 2009 | 27 | 0.080 |
Why?
| | Xanthine Oxidase | 1 | 2009 | 71 | 0.080 |
Why?
| | Databases, Factual | 3 | 2019 | 1125 | 0.080 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 947 | 0.080 |
Why?
| | Capillary Permeability | 1 | 2009 | 139 | 0.080 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 180 | 0.070 |
Why?
| | HIV Infections | 1 | 2019 | 2469 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1121 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 2 | 2014 | 2286 | 0.060 |
Why?
| | Comorbidity | 2 | 2019 | 1448 | 0.050 |
Why?
| | Registries | 2 | 2022 | 1768 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 42 | 0.050 |
Why?
| | Hypoxia | 1 | 2009 | 958 | 0.050 |
Why?
| | Delphi Technique | 1 | 2023 | 160 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4410 | 0.050 |
Why?
| | Incidence | 2 | 2018 | 2313 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 537 | 0.040 |
Why?
| | Renal Replacement Therapy | 1 | 2020 | 66 | 0.040 |
Why?
| | Educational Measurement | 1 | 2022 | 243 | 0.040 |
Why?
| | Antidiarrheals | 1 | 2019 | 15 | 0.040 |
Why?
| | Data Collection | 1 | 2022 | 620 | 0.040 |
Why?
| | Necrosis | 1 | 2020 | 211 | 0.040 |
Why?
| | Fungi | 1 | 2020 | 124 | 0.040 |
Why?
| | Debridement | 1 | 2019 | 73 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2019 | 60 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2019 | 52 | 0.040 |
Why?
| | Population Dynamics | 1 | 2019 | 123 | 0.040 |
Why?
| | Prognosis | 2 | 2018 | 3329 | 0.040 |
Why?
| | Independent Living | 1 | 2020 | 84 | 0.040 |
Why?
| | Aorta | 1 | 2021 | 386 | 0.040 |
Why?
| | Leadership | 1 | 2022 | 292 | 0.040 |
Why?
| | Hospital Costs | 1 | 2019 | 104 | 0.040 |
Why?
| | Organizational Innovation | 1 | 2019 | 132 | 0.040 |
Why?
| | California | 1 | 2019 | 353 | 0.040 |
Why?
| | Infant | 2 | 2023 | 7963 | 0.040 |
Why?
| | Postural Balance | 1 | 2020 | 183 | 0.040 |
Why?
| | Likelihood Functions | 1 | 2017 | 126 | 0.040 |
Why?
| | Child, Preschool | 2 | 2023 | 9116 | 0.030 |
Why?
| | Homicide | 1 | 2017 | 53 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2020 | 529 | 0.030 |
Why?
| | Acute Disease | 1 | 2019 | 911 | 0.030 |
Why?
| | Counseling | 1 | 2019 | 342 | 0.030 |
Why?
| | Probability | 1 | 2017 | 289 | 0.030 |
Why?
| | Communication | 1 | 2021 | 744 | 0.030 |
Why?
| | Burns, Chemical | 1 | 2016 | 25 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2017 | 170 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 478 | 0.030 |
Why?
| | Elasticity | 1 | 2016 | 189 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2017 | 114 | 0.030 |
Why?
| | Biliary Tract | 1 | 2015 | 16 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 55 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 224 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 187 | 0.030 |
Why?
| | Age Distribution | 1 | 2016 | 342 | 0.030 |
Why?
| | Blood Banks | 1 | 2015 | 40 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2019 | 490 | 0.030 |
Why?
| | Liver Function Tests | 1 | 2015 | 103 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 743 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1373 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2015 | 127 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 444 | 0.030 |
Why?
| | Risk | 1 | 2017 | 812 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 385 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 255 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1075 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1211 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2251 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2014 | 233 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2015 | 1226 | 0.030 |
Why?
| | International Normalized Ratio | 1 | 2012 | 45 | 0.030 |
Why?
| | Partial Thromboplastin Time | 1 | 2012 | 51 | 0.030 |
Why?
| | Platelet Count | 1 | 2012 | 81 | 0.030 |
Why?
| | Ultrasonography | 1 | 2015 | 634 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 234 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 80 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 1715 | 0.020 |
Why?
| | Child | 2 | 2023 | 18415 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 1660 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 713 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1481 | 0.020 |
Why?
| | Venules | 1 | 2009 | 13 | 0.020 |
Why?
| | Mesocricetus | 1 | 2009 | 29 | 0.020 |
Why?
| | Reperfusion | 1 | 2009 | 36 | 0.020 |
Why?
| | Cricetinae | 1 | 2009 | 253 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2380 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 5518 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2218 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1080 | 0.010 |
Why?
| | Rats | 1 | 2009 | 4958 | 0.010 |
Why?
| | Animals | 1 | 2009 | 31706 | 0.000 |
Why?
|
|
Cripps's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|